Literature DB >> 21737882

Mice lacking microRNA 133a develop dynamin 2–dependent centronuclear myopathy.

Ning Liu1, Svetlana Bezprozvannaya, John M Shelton, Madlyn I Frisard, Matthew W Hulver, Ryan P McMillan, Yaru Wu, Kevin A Voelker, Robert W Grange, James A Richardson, Rhonda Bassel-Duby, Eric N Olson.   

Abstract

MicroRNAs modulate cellular phenotypes by inhibiting expression of mRNA targets. In this study, we have shown that the muscle-specific microRNAs miR-133a-1 and miR-133a-2 are essential for multiple facets of skeletal muscle function and homeostasis in mice. Mice with genetic deletions of miR-133a-1 and miR-133a-2 developed adult-onset centronuclear myopathy in type II (fast-twitch) myofibers, accompanied by impaired mitochondrial function, fast-to-slow myofiber conversion, and disarray of muscle triads (sites of excitation- contraction coupling). These abnormalities mimicked human centronuclear myopathies and could be ascribed, at least in part, to dysregulation of the miR-133a target mRNA that encodes dynamin 2, a GTPase implicated in human centronuclear myopathy. Our findings reveal an essential role for miR-133a in the maintenance of adult skeletal muscle structure, function, bioenergetics, and myofiber identity; they also identify a potential modulator of centronuclear myopathies.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21737882      PMCID: PMC3148737          DOI: 10.1172/JCI46267

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  51 in total

Review 1.  Mechanisms of post-transcriptional regulation by microRNAs: are the answers in sight?

Authors:  Witold Filipowicz; Suvendra N Bhattacharyya; Nahum Sonenberg
Journal:  Nat Rev Genet       Date:  2008-02       Impact factor: 53.242

2.  Mitochondrial alterations in dynamin 2-related centronuclear myopathy.

Authors:  Edmar Zanoteli; Naja Vergani; Yvan Campos; Mariz Vainzof; Acary S B Oliveira; Alessandra d'Azzo
Journal:  Arq Neuropsiquiatr       Date:  2009-03       Impact factor: 1.420

3.  A new centronuclear myopathy phenotype due to a novel dynamin 2 mutation.

Authors:  M Bitoun; J A Bevilacqua; B Eymard; B Prudhon; M Fardeau; P Guicheney; N B Romero
Journal:  Neurology       Date:  2009-01-06       Impact factor: 9.910

4.  microRNA-133a regulates cardiomyocyte proliferation and suppresses smooth muscle gene expression in the heart.

Authors:  Ning Liu; Svetlana Bezprozvannaya; Andrew H Williams; Xiaoxia Qi; James A Richardson; Rhonda Bassel-Duby; Eric N Olson
Journal:  Genes Dev       Date:  2008-11-17       Impact factor: 11.361

5.  Protein kinase D1 stimulates MEF2 activity in skeletal muscle and enhances muscle performance.

Authors:  Mi-Sung Kim; Jens Fielitz; John McAnally; John M Shelton; Douglas D Lemon; Timothy A McKinsey; James A Richardson; Rhonda Bassel-Duby; Eric N Olson
Journal:  Mol Cell Biol       Date:  2008-03-31       Impact factor: 4.272

Review 6.  Role of mitochondrial dysfunction in insulin resistance.

Authors:  Jeong-A Kim; Yongzhong Wei; James R Sowers
Journal:  Circ Res       Date:  2008-02-29       Impact factor: 17.367

Review 7.  Centronuclear (myotubular) myopathy.

Authors:  Heinz Jungbluth; Carina Wallgren-Pettersson; Jocelyn Laporte
Journal:  Orphanet J Rare Dis       Date:  2008-09-25       Impact factor: 4.123

8.  Loss of myotubularin function results in T-tubule disorganization in zebrafish and human myotubular myopathy.

Authors:  James J Dowling; Andrew P Vreede; Sean E Low; Elizabeth M Gibbs; John Y Kuwada; Carsten G Bonnemann; Eva L Feldman
Journal:  PLoS Genet       Date:  2009-02-06       Impact factor: 5.917

Review 9.  miRNAS in normal and diseased skeletal muscle.

Authors:  Iris Eisenberg; Matthew S Alexander; Louis M Kunkel
Journal:  J Cell Mol Med       Date:  2009-01       Impact factor: 5.310

10.  AAV-mediated intramuscular delivery of myotubularin corrects the myotubular myopathy phenotype in targeted murine muscle and suggests a function in plasma membrane homeostasis.

Authors:  Anna Buj-Bello; Françoise Fougerousse; Yannick Schwab; Nadia Messaddeq; Danièle Spehner; Christopher R Pierson; Muriel Durand; Christine Kretz; Olivier Danos; Anne-Marie Douar; Alan H Beggs; Patrick Schultz; Marie Montus; Patrice Denèfle; Jean-Louis Mandel
Journal:  Hum Mol Genet       Date:  2008-04-22       Impact factor: 6.150

View more
  83 in total

1.  Histone deacetylases 1 and 2 regulate autophagy flux and skeletal muscle homeostasis in mice.

Authors:  Viviana Moresi; Michele Carrer; Chad E Grueter; Oktay F Rifki; John M Shelton; James A Richardson; Rhonda Bassel-Duby; Eric N Olson
Journal:  Proc Natl Acad Sci U S A       Date:  2012-01-17       Impact factor: 11.205

2.  The intragenic microRNA miR199A1 in the dynamin 2 gene contributes to the pathology of X-linked centronuclear myopathy.

Authors:  Xin Chen; Yun-Qian Gao; Yan-Yan Zheng; Wei Wang; Pei Wang; Juan Liang; Wei Zhao; Tao Tao; Jie Sun; Lisha Wei; Yeqiong Li; Yuwei Zhou; Zhenji Gan; Xuena Zhang; Hua-Qun Chen; Min-Sheng Zhu
Journal:  J Biol Chem       Date:  2020-04-29       Impact factor: 5.157

3.  Conditions that promote primary human skeletal myoblast culture and muscle differentiation in vitro.

Authors:  Cindy S Cheng; Yasser El-Abd; Khanh Bui; Young-Eun Hyun; Rebecca Harbuck Hughes; William E Kraus; George A Truskey
Journal:  Am J Physiol Cell Physiol       Date:  2013-12-11       Impact factor: 4.249

Review 4.  Sarcolipin: A Key Thermogenic and Metabolic Regulator in Skeletal Muscle.

Authors:  Meghna Pant; Naresh C Bal; Muthu Periasamy
Journal:  Trends Endocrinol Metab       Date:  2016-09-13       Impact factor: 12.015

5.  A micropeptide encoded by a putative long noncoding RNA regulates muscle performance.

Authors:  Douglas M Anderson; Kelly M Anderson; Chi-Lun Chang; Catherine A Makarewich; Benjamin R Nelson; John R McAnally; Prasad Kasaragod; John M Shelton; Jen Liou; Rhonda Bassel-Duby; Eric N Olson
Journal:  Cell       Date:  2015-01-29       Impact factor: 41.582

6.  Dynamin 2 the rescue for centronuclear myopathy.

Authors:  Alexis R Demonbreun; Elizabeth M McNally
Journal:  J Clin Invest       Date:  2014-02-24       Impact factor: 14.808

7.  Reducing dynamin 2 expression rescues X-linked centronuclear myopathy.

Authors:  Belinda S Cowling; Thierry Chevremont; Ivana Prokic; Christine Kretz; Arnaud Ferry; Catherine Coirault; Olga Koutsopoulos; Vincent Laugel; Norma B Romero; Jocelyn Laporte
Journal:  J Clin Invest       Date:  2014-02-24       Impact factor: 14.808

8.  In utero exposure to diesel exhaust particulates is associated with an altered cardiac transcriptional response to transverse aortic constriction and altered DNA methylation.

Authors:  Jamie M Goodson; Chad S Weldy; James W MacDonald; Yonggang Liu; Theo K Bammler; Wei-Ming Chien; Michael T Chin
Journal:  FASEB J       Date:  2017-07-27       Impact factor: 5.191

9.  Overexpression of NF90-NF45 Represses Myogenic MicroRNA Biogenesis, Resulting in Development of Skeletal Muscle Atrophy and Centronuclear Muscle Fibers.

Authors:  Hiroshi Todaka; Takuma Higuchi; Ken-ichi Yagyu; Yasunori Sugiyama; Fumika Yamaguchi; Keiko Morisawa; Masafumi Ono; Atsuki Fukushima; Masayuki Tsuda; Taketoshi Taniguchi; Shuji Sakamoto
Journal:  Mol Cell Biol       Date:  2015-04-27       Impact factor: 4.272

10.  Lipin-1 regulates autophagy clearance and intersects with statin drug effects in skeletal muscle.

Authors:  Peixiang Zhang; M Anthony Verity; Karen Reue
Journal:  Cell Metab       Date:  2014-06-12       Impact factor: 27.287

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.